Transcriptomic phenotyping offers mechanistic insight into adipocyte biology and metabolic disease. A signature of adipocyte ...

Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this ...

Spatial transcriptomics is transforming how scientists see biology—literally—by mapping gene activity in its original location inside tissues. From decoding tumor architecture to charting entire ...

Immune checkpoint blockade (ICB) has reshaped modern immunotherapy by unleashing antitumor immune responses through targeting inhibitory immune checkpoints ...

Temporomandibular joint disorders (TMDs) affect a large portion of the global population and are a common source of chronic ...

Temporomandibular joint (TMJ) osteoarthritis affects millions of people, yet the earliest molecular events behind the disease ...

Temporomandibular joint disorders (TMDs) affect a large portion of the global population and are a common source of chronic jaw pain and difficulty in ...

The advent of single-cell omics technologies has revolutionized our understanding of the complex cellular landscape in cancer. Traditional bulk sequencing ...

Takara Bio USA, Inc. today announced a benchmark study comparing the performance of its Trekker® FX technology against ...

Spatial transcriptomics (ST) has revolutionized biomedical research by enabling scientists to measure gene expression while ...

Abstract: Spatial transcriptomics technology enables researchers to acquire both spatial location information and gene expression data within tissues, providing new perspectives for understanding ...

Here, we present Randomized Spatial PCA (RASP), a novel spatially aware dimensionality reduction method for spatial transcriptomics (ST) data. RASP is designed to be orders-of-magnitude faster than ...